Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent
Tobin, A.M.; Barragry, J.; Kirby, B.; O'Shea, L.
Irish Medical Journal 98(4): 118
2005
ISSN/ISBN: 0332-3102 PMID: 15938560 Document Number: 592003
Document emailed within 1 workday
Related Documents
Young, C.A.; Williams, I.R.; MacFarlane, I.A. 1991: Unrecognised Cushing's syndrome and adrenal suppression due to topical clobetasol propionate British Journal of Clinical Practice 45(1): 61-62Breneman, D.; Fleischer, A.B.; Kaplan, D.; Lebwohl, M.; Miller, B.; Pariser, D.; Rist, T.; Swinyer, L.; Liu, Y.; Foley, V. 2005: Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream Journal of Drugs in Dermatology: Jdd 4(3): 330-336
Camacho, F.; Mazuecos, J.é 2002: Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo Journal of Drugs in Dermatology: Jdd 1(2): 127-131
Lane, P.R.; Moreland, A.A.; Hogan, D.J. 1990: Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report Archives of Dermatology 126(9): 1211-1213
Thomas, J.; Kandhari, S.; Oberoi, C.; Jayaseelan, E.; Raj, K.Y. 2001: A double - blind randomised multicentre controlled study of topical 0.05% clobetasol propionate with 2.5% zinc sulphate preparation Indian Journal of Dermatology Venereology and Leprology 67(3): 135-137
Gans, E.H.; Sadiq, I.; Stoudemayer, T.; Stoudemayer, M.; Kligman, A.M. 2008: In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle Journal of Drugs in Dermatology: Jdd 7(1): 28-32
Lorenz, B.; Kaufman, R.H.; Kutzner, S.K. 1998: Lichen sclerosus. Therapy with clobetasol propionate Journal of Reproductive Medicine 43(9): 790-794
Warino, L.; Balkrishnan, R.; Feldman, S.R. 2006: Clobetasol propionate for psoriasis: are ointments really more potent? Journal of Drugs in Dermatology: Jdd 5(6): 527-532
Hradil, E.; Lindström, C.; Möller, H. 1978: Intermittent treatment of psoriasis with clobetasol propionate Acta Dermato-Venereologica 58(4): 375-377
Iankelevich, D.E.; Iurchenko, M.Z. 1970: The effect of prolonged administration of testosterone propionate and 2-alpha-methyldihyrotestosterone propionate on several functions of the adrenal cortex in female guinea pigs Problemy Endokrinologii 16(6): 70-73
Esser, B. 1979: Comparative study of clobetasol 17-propionate and traimcinolone acetonide Zeitschrift für Hautkrankheiten 54(20): 893-897
Khalid, M.; Mujtaba, G. 1998: Response of segmental vitiligo to 0.05% clobetasol propionate cream International Journal of Dermatology 37(9): 705-708
Geraldez, C.B.; Gutierrez, G.T. 1987: A clinical trial of clobetasol propionate in Filipino vitiligo patients Clinical Therapeutics 9(5): 474-482
Nielsen, P.G. 1993: Calcipotriol or clobetasol propionate occluded with a hydrocolloid dressing for treatment of nummular psoriasis Acta Dermato-Venereologica 73(5): 394
Lahfa, M.; Mrowietz, U.; Koenig, M.; Simon, J.C. 2003: Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis European Journal of Dermatology: Ejd 13(3): 261-265
Jarratt, M.; Breneman, D.; Gottlieb, A.B.; Poulin, Y.; Liu, Y.; Foley, V. 2004: Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis Journal of Drugs in Dermatology: Jdd 3(4): 367-373
Jarratt, M.T.; Clark, S.D.; Savin, R.C.; Swinyer, L.J.; Safley, C.F.; Brodell, R.T.; Yu, K. 2006: Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis Cutis 78(5): 348-354
Ziebolz, D.; Hannig, C.; Attin, T. 2008: Influence of a desensitizing agent on efficacy of a paint-on bleaching agent American Journal of Dentistry 21(2): 77-82
Menter, M.A.; Caveney, S.W.; Gottschalk, R.W. 2012: Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis Journal of Drugs in Dermatology: Jdd 11(11): 1348-1354
Feldman, S.R.; Winkelman, W.; Baum, E.; Preston, N. 2013: Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray Journal of Drugs in Dermatology: Jdd 12(12): 1456-1460